rhodioloside has been researched along with Disbacteriosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Dai, Z; He, Z; Liu, X; Luo, S; Shi, Y; Zhou, M | 1 |
| Hong, Y; Wu, X; Yan, H; Yuan, Y; Zhang, X | 1 |
2 other study(ies) available for rhodioloside and Disbacteriosis
| Article | Year |
|---|---|
Salidroside alleviates ulcerative colitis via inhibiting macrophage pyroptosis and repairing the dysbacteriosis-associated Th17/Treg imbalance.
Topics: Animals; Colitis; Colitis, Ulcerative; Dextran Sulfate; Dysbiosis; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; T-Lymphocytes, Regulatory; Triggering Receptor Expressed on Myeloid Cells-1 | 2023 |
Ameliorative effect of salidroside from Rhodiola Rosea L. on the gut microbiota subject to furan-induced liver injury in a mouse model.
Topics: Animals; Bacteria; Chemical and Drug Induced Liver Injury; Cytokines; DNA, Bacterial; DNA, Ribosomal; Dysbiosis; Furans; Gastrointestinal Microbiome; Glucosides; Inflammation; Lipopolysaccharides; Liver; Male; Mice, Inbred BALB C; Phenols; Proteobacteria; Rhodiola; Verrucomicrobia | 2019 |